Nippon India Pharma Fund-Growth Plan-Bonus Option vs Nippon India Power & Infra Fund - Direct Plan Growth Plan - Bonus Option
Side-by-side comparison of NAV, returns, expense ratio and star rating.
TopFund Analysis
Nippon India Power & Infra Fund - Direct Plan Growth Plan - Bonus Option appears stronger based on its higher star rating of 4 compared to the 2-star rating of Nippon India Pharma Fund-Growth Plan-Bonus Option, indicating better overall performance and management. However, this fund comes with a higher expense ratio of 1.11% compared to the 0.99% of the Pharma Fund, which may impact net returns. Investors should consider the tradeoff between the higher potential long-term returns of the Power & Infra Fund and its higher costs.
Nippon India Pharma Fund-Growth Plan-Bonus Option
Nippon India Mutual Fund
★★★★★
Equity · Sectoral Fund
Nippon India Power & Infra Fund - Direct Plan Growth Plan - Bonus Option
Nippon India Mutual Fund
★★★★★
Equity · Sectoral Fund
| Metric | Nippon India Pharma Fu... | Nippon India Power & I... |
|---|---|---|
| NAV | ₹582.42 | ₹403.71 |
| Star Rating | ★★ | ★★★★ |
| Expense Ratio | 0.99% | 1.11% |
| AUM | ₹9,166 Cr | ₹7,866 Cr |
| 1M Return | +8.53% | +3.42% |
| 3M Return | +2.09% | -4.33% |
| 6M Return | +6.88% | -1.54% |
| 1Y Return | +11.76% | +5.0% |
| 3Y CAGR | +16.54% | +16.07% |
| 5Y CAGR | +13.76% | +18.95% |
| Risk Level | — | — |
| Fund Manager | Sailesh Raj Bhan | Sanjay Doshi |